Screeners
Heatmaps
Trends
News

You're viewing limited data.

Sign up

1 asset

Market news

TypeAll

SortNewest

Assets

BCYC

Type

TypeAll

All

Sort

SortNewest

Newest

Filter by asset

Bicycle Therapeutics Announces Board and Advisory Resignation

Detailed price information for Bicycle Therapeutics Plc ADR (BCYC-Q) from The Globe and Mail including charting and trades.

Aug 21The Globe and Mail

Analysts’ Opinions Are Mixed on These Healthcare Stocks: OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmaceuticals, Inc. (SXTP)

Detailed price information for 60 Degrees Pharmaceuticals Inc (SXTP-Q) from The Globe and Mail including charting and trades.

Aug 18The Globe and Mail

Bicycle: 'Hold' On Zelenectide Deprioritization And Shift To EphA2+ Tumor Targeting

Aug 4Seeking Alpha

RBC Capital Keeps Their Hold Rating on Bicycle Therapeutics (BCYC)

Detailed price information for Bicycle Therapeutics Plc ADR (BCYC-Q) from The Globe and Mail including charting and trades.

Aug 1The Globe and Mail

Truist Financial Remains a Hold on Bicycle Therapeutics (BCYC)

Detailed price information for Bicycle Therapeutics Plc ADR (BCYC-Q) from The Globe and Mail including charting and trades.

Aug 1The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC), Alnylam Pharma (ALNY) and Fortrea Holdings Inc. (FTRE)

Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.

Jul 31theglobeandmail.com

Bicycle a new outperform at Oppenheimer on platform to treat cancer (BCYC:NASDAQ)

Jul 31Seeking Alpha

Bicycle Therapeutics earnings missed by $0.15, revenue fell short of estimates

Jul 30Investing.com

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results

CAMBRIDGE, England & BOSTON, July 30, 2026--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today reported financial results for the second quarter ended June 30, 2026, and provided recent corporate updates.

Jul 30Yahoo Finance

UK Minister Defends US Pharma Deal Following Calls to Scrap It

Jul 10bloomberg.com

This is the newest page. Registered accounts read further back.